Age-associated changes in cardiac structure and function, together with
estrogen loss, contribute to the progression of
heart failure with preserved ejection fraction in older women. To investigate the effects of aging and
estrogen loss on the development of its precursor, asymptomatic
left ventricular diastolic dysfunction, echocardiograms were performed in 10 middle-aged (20 months) and 30 old-aged (30 months) female Fischer344×Brown-Norway rats, 4 and 8 weeks after
ovariectomy (OVX) and
sham procedures (gonads left intact). The cardioprotective potential of administering chronic G1, the selective agonist to the new
G-protein-coupled
estrogen receptor (GPER), was further evaluated in old rats (Old-OVX+G1) versus age-matched, vehicle-treated OVX and gonadal intact rats. Advanced age and
estrogen loss led to decreases in myocardial relaxation and elevations in filling pressure, in part, due to reductions in phosphorylated
phospholamban and increases in cardiac
collagen deposition. Eight weeks of
G-protein-coupled
estrogen receptor activation in Old-OVX+G1 rats reversed the adverse effects of age and
estrogen loss on myocardial relaxation through increases in sarcoplasmic reticulum
Ca2+ ATPase expression and reductions in interstitial
fibrosis. These findings may explain the preponderance of
heart failure with preserved ejection fraction in older postmenopausal women and provide a promising, late-life therapeutic target to reverse or halt the progression of
left ventricular diastolic dysfunction.